-
Something wrong with this record ?
Molecular mechanisms of antineoplastic action of an anticancer drug ellipticine
M. Stiborova, M. Rupertova, HH. Schmeiser, E. Frei
Language English Country Czech Republic
Document type Journal Article, Research Support, Non-U.S. Gov't, Review
NLK
Directory of Open Access Journals
from 2001
Free Medical Journals
from 1998
ROAD: Directory of Open Access Scholarly Resources
from 2001
PubMed
16936898
DOI
10.5507/bp.2006.002
Knihovny.cz E-resources
- MeSH
- DNA Adducts drug effects MeSH
- Ellipticines chemistry pharmacology MeSH
- Humans MeSH
- Oxidation-Reduction MeSH
- Antineoplastic Agents chemistry pharmacology MeSH
- Cytochrome P-450 Enzyme System metabolism MeSH
- Animals MeSH
- Check Tag
- Humans MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
- Review MeSH
Ellipticine is a potent antineoplastic agent exhibiting the multimodal mechanism of its action. This article reviews the mechanisms of predominant pharmacological and cytotoxic effects of ellipticine and shows the results of our laboratories indicating a novel mechanism of its action. The prevalent mechanisms of ellipticine antitumor, mutagenic and cytotoxic activities were suggested to be intercalation into DNA and inhibition of DNA topoisomerase II activity. We demonstrated a new mode of ellipticine action, formation of covalent DNA adducts mediated by its oxidation with cytochromes P450 (CYP) and peroxidases. The article reports the molecular mechanism of ellipticine oxidation by CYPs and identifies human and rat CYPs responsible for ellipticine metabolic activation and detoxication. It also presents a role of peroxidases (i.e. myeloperoxidase, cyclooxygenases, lactoperoxidase) in ellipticine oxidation leading to ellipticine-DNA adducts. The 9-hydroxy- and 7-hydroxyellipticine metabolites formed by CYPs and the major product of ellipticine oxidation by peroxidases, the dimer, in which the two ellipticine skeletons are connected via N(6) of the pyrrole ring of one ellipticine molecule and C9 in the second one, are the detoxication metabolites. On the contrary, 13-hydroxy- and 12-hydroxyellipticine, produced by ellipticine oxidation with CYPs, the latter one formed also spontaneously from another CYP- and peroxidase-mediated metabolite, ellipticine N(2)-oxide, are metabolites responsible for formation of two ellipticine-derived deoxyguanosine adducts in DNA. The results reviewed here allow us to propose species, two carbenium ions, ellipticine-13-ylium and ellipticine-12-ylium, as reactive species generating two major DNA adducts seen in vivo in rats treated with ellipticine. The study forms the basis to further predict the susceptibility of human cancers to ellipticine.
Department of Biochemistry Faculty of Science Charles University Prague
Division of Molecular Toxicology German Cancer Research Center Im Neuenheimer Feld 280 Heidelberg
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13003704
- 003
- CZ-PrNML
- 005
- 20130315141541.0
- 007
- ta
- 008
- 130128s2006 xr d f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.5507/bp.2006.002 $2 doi
- 035 __
- $a (PubMed)16936898
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xr
- 100 1_
- $a Stiborová, Marie, $d 1950-2020 $7 jo2005259907 $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2
- 245 10
- $a Molecular mechanisms of antineoplastic action of an anticancer drug ellipticine / $c M. Stiborova, M. Rupertova, HH. Schmeiser, E. Frei
- 520 9_
- $a Ellipticine is a potent antineoplastic agent exhibiting the multimodal mechanism of its action. This article reviews the mechanisms of predominant pharmacological and cytotoxic effects of ellipticine and shows the results of our laboratories indicating a novel mechanism of its action. The prevalent mechanisms of ellipticine antitumor, mutagenic and cytotoxic activities were suggested to be intercalation into DNA and inhibition of DNA topoisomerase II activity. We demonstrated a new mode of ellipticine action, formation of covalent DNA adducts mediated by its oxidation with cytochromes P450 (CYP) and peroxidases. The article reports the molecular mechanism of ellipticine oxidation by CYPs and identifies human and rat CYPs responsible for ellipticine metabolic activation and detoxication. It also presents a role of peroxidases (i.e. myeloperoxidase, cyclooxygenases, lactoperoxidase) in ellipticine oxidation leading to ellipticine-DNA adducts. The 9-hydroxy- and 7-hydroxyellipticine metabolites formed by CYPs and the major product of ellipticine oxidation by peroxidases, the dimer, in which the two ellipticine skeletons are connected via N(6) of the pyrrole ring of one ellipticine molecule and C9 in the second one, are the detoxication metabolites. On the contrary, 13-hydroxy- and 12-hydroxyellipticine, produced by ellipticine oxidation with CYPs, the latter one formed also spontaneously from another CYP- and peroxidase-mediated metabolite, ellipticine N(2)-oxide, are metabolites responsible for formation of two ellipticine-derived deoxyguanosine adducts in DNA. The results reviewed here allow us to propose species, two carbenium ions, ellipticine-13-ylium and ellipticine-12-ylium, as reactive species generating two major DNA adducts seen in vivo in rats treated with ellipticine. The study forms the basis to further predict the susceptibility of human cancers to ellipticine.
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a protinádorové látky $x chemie $x farmakologie $7 D000970
- 650 _2
- $a systém (enzymů) cytochromů P-450 $x metabolismus $7 D003577
- 650 _2
- $a adukty DNA $x účinky léků $7 D018736
- 650 _2
- $a elipticiny $x chemie $x farmakologie $7 D004611
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a oxidace-redukce $7 D010084
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 655 _2
- $a přehledy $7 D016454
- 700 1_
- $a Rupertová, Martina. $7 _AN043711 $u Department of Biochemistry, Faculty of Science, Charles University, Prague 2
- 700 1_
- $a Schmeiser, Heinz H. $u Division of Molecular Toxicology, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg
- 700 1_
- $a Frei, Eva. $7 _AN036392 $u Division of Molecular Toxicology, German Cancer Research Center, Im Neuenheimer Feld 280, Heidelberg
- 773 0_
- $w MED00012606 $t Biomedical papers of the Medical Faculty of the University Palacký, Olomouc, Czech Republic $x 1213-8118 $g Roč. 150, č. 1 (2006), s. 13-23
- 910 __
- $a ABA008 $b A 1502 $c sign $y 3 $z 0
- 990 __
- $a 20130128 $b ABA008
- 991 __
- $a 20130315141758 $b ABA008
- 999 __
- $a ok $b bmc $g 966360 $s 801899
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2006 $b 150 $c 1 $d 13-23 $i 1213-8118 $m Biomedical papers of the Medical Faculty of the University Palacký, Olomouc Czech Republic $n Biomed. Pap. Fac. Med. Palacký Univ. Olomouc Czech Repub. (Print) $x MED00012606
- LZP __
- $b NLK111 $a Pubmed-20130128